Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 3,840 shares at $148.93 ($569K) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Open-market sale of $569k JAZZ by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.93 | 1,056 | $157K | 27.7% |
| 2 | $148.93 | 1,056 | $157K | 27.7% |
| 3 | $150.49 | 11 | $2K | 0.3% |
| 4 | $144.18 | 273 | $39K | 6.9% |
| 5 | $147.51 | 722 | $107K | 18.7% |
| 6 | $147.51 | 722 |
| $107K |
| 18.7% |
| Total | $148.06 avg | 3,840 | $569K | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |